1.29Open1.39Pre Close6 Volume41 Open Interest81.00Strike Price870.00Turnover115.68%IV0.23%PremiumDec 13, 2024Expiry Date2.07Intrinsic Value100Multiplier0DDays to Expiry0.18Extrinsic Value100Contract SizeAmericanOptions Type-0.7274Delta0.1019Gamma30.36Leverage Ratio-1.1750Theta-0.0007Rho-22.08Eff Leverage0.0094Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet